Dr Padma R Chimata Md Houston, TX - 77094

Dr Padma R Chimata Md is categorized under Internal Medicine Practitioners in Houston, TX and active since 2012.

Dr Padma R Chimata Md was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Padma Rao Chimata at the company’s single location by writing to 19770 Kingsland Boulevard # 305, Houston, Texas TX 77094 or by phoning (281) 578-7438. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr Padma R Chimata Md
Contact Person: Padma Rao Chimata
Address: 19770 Kingsland Boulevard # 305, Houston, Texas 77094
Phone Number: (281) 578-7438
Website Address: katyrheumatology.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Dr Padma R Chimata Md was started in 2012 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Padma Rao Chimata for inquiries that concern Dr Padma R Chimata Md by calling the company number (281) 578-7438, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Padma R Chimata Md can be found at the coordinates 29.775877,-95.714662 as well as the street address 19770 Kingsland Boulevard # 305 in Houston, Texas 77094.

For its online presence, you may visit Dr Padma R Chimata Md’s website at katyrheumatology.com and engage with its social media outlets through on Twitter and on Facebook.